Kai-Yan Liu (Peihua Lu)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 14

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Ejection Fraction

Top Venues

American journal of hematology

Cancer immunology, immunotherapy : CII

Molecular carcinogenesis

This page only lists publications with an associated author ORCID identifier.

Publications

Xue Chen, Lili Yuan, Yang Zhang, Fang Wang, Xiaoli Ma, Jiancheng Fang, Panxiang Cao, Yijun Liu, Zhixiu Liu, Ming Liu, Jiaqi Chen, Xiaosu Zhou, Mingyue Liu, David Jin, Tong Wang, Kai-Yan Liu, Hongxing Liu
Advances towards genome-based acute myeloid leukemia classification: A comparative analysis of WHO-HAEM4R, WHO-HAEM5, and International Consensus Classification. American journal of hematology (2024)
Xue Chen, Lili Yuan, Yang Zhang, Fang Wang, Xiaoli Ma, Jiancheng Fang, Panxiang Cao, Yijun Liu, Zhixiu Liu, Ming Liu, Jiaqi Chen, Xiaosu Zhou, Mingyue Liu, David Jin, Tong Wang, Kai-Yan Liu, Hongxing Liu
Advances towards genome-based acute myeloid leukemia classification: A comparative analysis of WHO-HAEM4R, WHO-HAEM5, and International Consensus Classification. American journal of hematology 99 (5) (2024)
Xiaosu Zhou, Xue Chen, Jiaqi Chen, Lijun Wen, Zhanglin Zhang, Ya-Zhen Qin, Panxiang Cao, Haizhou Xing, Yingchang Mi, Wei Wang, Guangsen Sen Zhang, Ji Li, Huanling Wu, Zhifen Zhang, Jian Zhang, Zhan Su, Fang Wang, Yang Zhang, Xiaoli Ma, Jiancheng Fang, Ping Wu, Tong Wang, Gaowei Fan, Yang Zhao, David Jin, Xian Zhang, Xiujuan Ma, Qisheng Wu, Zhihua Zhang, Linya Wang, Futian Ma, Xia Xiao, Chengye Wu, Kai Sun, Ruijie Tang, Yun Zhang, Sanyun Wu, Ran Gao, Leping Zhang, Huyong Zheng, Yanli Zhao, Hong Hu Zhu, Daopei Lu, Kai-Yan Liu, Su-Ning Chen, Hongxing Liu
Critical Role of Tripartite Fusion and LBD Truncation in Certain RARA- and all RARG-Related Atypical APL. Blood (2024)
Xue Chen, Lili Yuan, Yang Zhang, Fang Wang, Xiaoli Ma, Jiancheng Fang, Panxiang Cao, Yijun Liu, Zhixiu Liu, Ming Liu, Jiaqi Chen, Xiaosu Zhou, Mingyue Liu, David Jin, Tong Wang, Kai-Yan Liu, Hongxing Liu
Advances towards genome-based acute myeloid leukemia classification: A comparative analysis of WHO-HAEM4R, WHO-HAEM5, and International Consensus Classification. American journal of hematology 99 (5) (2024)
Xue Chen, Lili Yuan, Yang Zhang, Fang Wang, Xiaoli Ma, Jiancheng Fang, Panxiang Cao, Yijun Liu, Zhixiu Liu, Ming Liu, Jiaqi Chen, Xiaosu Zhou, Mingyue Liu, David Jin, Tong Wang, Kai-Yan Liu, Hongxing Liu
Advances towards genome-based acute myeloid leukemia classification: A comparative analysis of WHO-HAEM4R, WHO-HAEM5, and International Consensus Classification. American journal of hematology 99 (5) (2024)
Xiaosu Zhou, Daijing Nie, Yang Zhang, Zhixiu Liu, Yan-Li Zhao, Jianping Zhang, Fang Wang, Jiancheng Fang, Panxiang Cao, Xue Chen, Xiaoli Ma, Lili Yuan, Jiaqi Chen, Yincheng Tan, Qihui Chen, Ming Liu, Mingyue Liu, Yijun Liu, Qisheng Wu, Kai-Yan Liu, Hongxing Liu
DNTT activation, TdT-aided gene length mutation, and better prognosis in ATG-based regimen allo-HSCT in AML. Molecular carcinogenesis (2023)
Xian Zhang, Junfang Yang, Jingjing Li, Liyuan Qiu, Jianping Zhang, Yue Lu, Yan-Li Zhao, David Jin, Jianqiang Li, Kai-Yan Liu
Analysis of 60 patients with relapsed or refractory T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma treated with CD7-targeted chimeric antigen receptor-T cell therapy. American journal of hematology (2023)
Jiasheng Wang, Xian Zhang, Zhixiao Zhou, Yue Liu, Li Yu, Lemei Jia, Junfang Yang, Jingjing Li, Hanyang Yu, Wenzhong Li, Guangna Liu, Wei Rui, Hongli Zheng, Xueqiang Zhao, Xin Lin, Kai-Yan Liu
A novel adoptive synthetic TCR and antigen receptor (STAR) T-Cell therapy for B-Cell acute lymphoblastic leukemia. American journal of hematology 97 (8) (2022)
Kai-Yan Liu, Ying Liu, Junfang Yang, Xian Zhang, Xiao Yang, Hui Wang, Lin Wang, Qinglong Wang, David Jin, Jianqiang Li, Xiao-Jun Huang
Naturally selected CD7 CAR-T therapy without genetic manipulations for T-ALL/LBL: first-in-human phase 1 clinical trial. Blood 140 (4) (2022)
Xiangqun Li, Kylan Chen, Hailong Zhang, Xian Zhang, Junfang Yang, Jing Liu, Jianwei Zheng, Fei Dong, Yongbo Zhu, Jiao Yu, Haihong Zhang, Kai-Yan Liu, Bo Chen
Anti-CD19 CAR T as a feasible therapy for refractory/relapsed mixed phenotype acute leukemia patients. Pediatric blood & cancer 69 (10) (2022)
Junfang Yang, Jiaping He, Xian Zhang, Jingjing Li, Zhenguang Wang, Yongliang Zhang, Liyuan Qiu, Qionglu Wu, Zhe Sun, Xun Ye, Wenjie Yin, Wei Cao, Lianjun Shen, Martina Sersch, Kai-Yan Liu
Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study. Blood cancer journal 12 (7) (2022)
Guangna Liu, Hua Chen, Xingyu Cao, Lemei Jia, Wei Rui, Hongli Zheng, Daosheng Huang, Fang Liu, Yue Liu, Xueqiang Zhao, Kai-Yan Liu, Xin Lin
Efficacy of pp65-specific TCR-T cell therapy in treating cytomegalovirus infection after hematopoietic stem cell transplantation. American journal of hematology 97 (11) (2022)
Xing-Yu Cao, Jing-Jing Li, Pei-Hua Lu, Kai-Yan Liu
Efficacy and safety of CD19 CAR-T cell therapy for acute lymphoblastic leukemia patients relapsed after allogeneic hematopoietic stem cell transplantation. International journal of hematology 116 (3) (2022)
Xian Zhang, Junfang Yang, Jingjing Li, Wenqian Li, Dan Song, Xin-An Lu, Fei Wu, Jianqiang Li, Dandan Chen, Xiangqun Li, Zhongwei Xu, Shuqiang Liu, Ziyu Li, Kui Ying, Kai-Yan Liu
Factors associated with treatment response to CD19 CAR-T therapy among a large cohort of B cell acute lymphoblastic leukemia. Cancer immunology, immunotherapy : CII (2021)